MLYS
Price
$23.64
Change
-$0.08 (-0.34%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
2.27B
45 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$35.73
Change
+$0.23 (+0.65%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
26.71B
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLYS vs ROIV

MLYS vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
MLYS vs. ROIV commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Buy and ROIV is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
MLYSROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 8 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (MLYS: $23.72 vs. ROIV: $35.50)
Brand notoriety: MLYS and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 147% vs. ROIV: 39%
Market capitalization -- MLYS: $2.27B vs. ROIV: $26.71B
MLYS [@Biotechnology] is valued at $2.27B. ROIV’s [@Biotechnology] market capitalization is $26.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green while ROIV’s FA Score has 1 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 3 bullish TA indicator(s).

  • MLYS’s TA Score: 4 bullish, 6 bearish.
  • ROIV’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than ROIV.

Price Growth

MLYS (@Biotechnology) experienced а -10.79% price change this week, while ROIV (@Biotechnology) price change was -1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 16, 2026.

ROIV is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MLYS
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMIG31.080.17
+0.55%
Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG)
BREE27.350.06
+0.20%
MFS Blended Research Emerging Markets Equity ETF (BREE)
TSIC23.78N/A
N/A
Truth Social American Icons ETF Amrn Icons ETF (TSIC)
NBFC49.02-0.26
-0.53%
Neuberger Flexible Credit Income ETF (NBFC)
MORT8.01-0.40
-4.76%
VanEck Mortgage REIT Income ETF (MORT)

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with NKTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-5.61%
NKTX - MLYS
41%
Loosely correlated
-2.29%
COGT - MLYS
40%
Loosely correlated
-1.34%
ROIV - MLYS
40%
Loosely correlated
-2.93%
BCYC - MLYS
39%
Loosely correlated
-3.26%
DNLI - MLYS
39%
Loosely correlated
-0.68%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-2.93%
IMVT - ROIV
62%
Loosely correlated
-0.38%
AXON - ROIV
43%
Loosely correlated
-0.07%
IMTX - ROIV
42%
Loosely correlated
-3.87%
DNTH - ROIV
40%
Loosely correlated
+0.31%
MLYS - ROIV
39%
Loosely correlated
-5.61%
More